Oral Thin Films Market
Number of pages: 100 | Report Format: PDF | Published date: 15 March, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market size value in 2022 |
US$ 2.82 billion |
|
Revenue forecast in 2031 |
US$ 5.41 billion |
|
Growth Rate |
CAGR of 8.5% from 2023 to 2031 |
|
Base year for estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments covered |
Product, Disease Indication, Distribution Channel, and Region. |
|
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global oral thin films market was valued at US$ 2.82 billion in 2022 and is expected to register a revenue CAGR of 8.5% to reach US$ 5.41 billion by 2031.
Market Fundamentals
The global oral thin films market is expected to experience considerable growth during the forecast years due to increasing demand for easy-to-use drug delivery systems, the rising prevalence of chronic diseases, and the growing geriatric population. Oral thin films offer several advantages over traditional drug delivery methods, including convenience, ease of use, and improved patient compliance. They are also ideal for delivering drugs with a narrow therapeutic window or requiring precise dosing. The market for oral thin films is also expected to benefit from the increasing adoption of personalized medicine. Oral thin films can be customized to meet the specific needs of individual patients, making them an attractive option for personalized drug delivery.
North America is the largest market for oral thin films, followed by Europe and Asia-Pacific. The region is home to a large number of pharmaceutical companies that are investing in the development and commercialization of oral thin films. Additionally, the increasing demand for pain management drugs and a well-established healthcare infrastructure are driving market growth in this region.
However, the high cost of developing and producing oral thin films is a major market challenge. In addition, there is a lack of awareness & understanding among patients and healthcare providers regarding the benefits and applications of oral thin films.
Oral thin films are a pharmaceutical dosage form designed to dissolve rapidly in the mouth when placed on or under the tongue. Oral thin films are flexible films made from a combination of polymers, plasticizers, and other ingredients that are dissolved in a solvent and then cast into a thin film. They can deliver various medications, including pain relievers, allergy medications, and vitamins. They offer several advantages over traditional dosage forms, such as improved patient compliance, faster onset of action, and increased convenience.
[46456]
Market Dynamics
The global prevalence of chronic diseases is rising, resulting in an escalating demand for advanced drug delivery systems. Oral thin films offer an attractive alternative to conventional dosage forms by providing a convenient and effective solution for patients with chronic conditions. Additionally, oral thin films provide benefits such as improved bioavailability, faster onset of action, and ease of use compared to traditional dosage forms, driving the adoption of oral thin films. There is a growing demand for non-invasive drug delivery systems that are more convenient than traditional methods. Oral thin films offer a non-invasive drug delivery option. Innovations in drug delivery technology are spurring growth in the oral thin films market, as new and improved products are being developed to meet patient needs. The demand for pain management drugs is also driving the growth of the oral thin films market.
Many pharmaceutical companies are developing oral thin films specifically for pain management, further boosting the growth of oral thin films. The growing demand for personalized medicine is increasing the development of customized oral thin films tailored to patients’ needs. There is growing investment in research & development in oral thin films, with pharmaceutical companies and other stakeholders investing in developing new products and technologies, thus fueling the growth of the global oral thin films market. However, the limited awareness and adoption of oral thin films are restricting the growth of the oral thin films market. The presence of alternate drug delivery options and the limit on drug dosages are also hindering the growth of the global oral thin films market.
Market Ecosystem
The global oral thin films market is analyzed from four perspectives: Product, Disease Indication, Distribution Channel, and Region.
Oral Thin Films Market by Product
[6435634]
Based on the product, the global oral thin films market is segmented into sublingual film and fast dissolving dental/buccal film.
The sublingual film segment dominated the oral thin films market with the largest revenue share. Sublingual films offer a faster and more effective mode of medication delivery by dissolving rapidly in the mouth and allowing direct absorption into the bloodstream through the mucous membranes under the tongue, bypassing the digestive system. The sublingual films are easy to use and can be taken discreetly, making them a popular choice for patients who prefer not to swallow pills or liquids. They also do not require water or special handling, making them convenient for use on the go, increasing the demand for sublingual film. Sublingual films can be used for various applications, including pain management, allergy relief, smoking cessation, and more, thus increasing the demand for the sublingual film for different diseases.
The fast dissolving dental/buccal film segment accounted for the second-largest revenue share of the oral thin films market.Dental/buccal film allows for precise drug delivery, enabling accurate dosing and enhanced bioavailability. This makes them an appealing option for pharmaceutical companies looking to improve the efficacy of their products. Fast-dissolving dental/buccal films have emerged as a viable alternative to traditional oral medications as more patients seek non-invasive drug delivery options, propelling the segment’s growth.
Oral Thin Films Market by Disease Indication
Based on the disease indication, the global oral thin films market is segmented into schizophrenia, migraine, opioid dependence, nausea & vomiting, and others.
With the highest revenue share, the schizophrenia segment dominated the oral thin films market. The rising incidence of schizophrenia patients globally increases the demand for effective treatment and delivery mechanisms. According to the WHO, about 24 million people, or 1 in every 300 people, are affected by schizophrenia globally. Schizophrenia patients often face difficulty adhering to medication due to symptoms like cognitive impairment and lack of insight. Oral thin films provide a convenient and easy-to-use option that may help enhance patient compliance. The rapid dissolution of oral thin films in the mouth facilitates swift medication delivery, making it a suitable option for individuals experiencing acute schizophrenia symptoms. Additionally, the non-invasive nature of oral thin films, compared to injections and other invasive methods, makes it a more socially acceptable and less stigmatizing option for schizophrenia patients.
The migraine segment is expected to grow at a lucrative rate during the forecast period. The prevalence of migraine has been increasing globally, with more people being diagnosed with this condition. According to the National Center for Biotechnology Information, approximately 1 billion individuals are affected by migraine every year globally. Oral thin films are an effective and convenient treatment option for migraine. These films dissolve rapidly in the mouth and deliver the medication directly to the bloodstream, quickly relieving migraine symptoms. Moreover, patients suffering from migraine experience nausea during an attack, so the oral route of drug delivery can be preferable to other routes. The development of innovative technologies and advancements in drug delivery systems has introduced more effective and targeted therapies for migraine. Oral thin films are one such technology that has gained popularity due to their ease of use and effectiveness.
Oral Thin Films Market by Distribution Channel
Based on distribution channel, the global oral thin films market is segmented into hospital pharmacies, retail pharmacies, and other distribution channels.
The retail pharmacies accounted for the largest revenue share of the oral thin films market in 2022. Patients may easily visit retail pharmacies, and since these pharmacies have oral thin films products, it is easier for patients to buy and utilize these products. To improve patient outcomes and satisfaction, retail pharmacists counsel and advise patients on using oral thin film products. Most insurance policies cover prescription drugs purchased at retail pharmacies, making it simpler and cheaper for patients to purchase oral thin films products from these pharmacies.
Oral Thin Films Market by Region
The global oral thin films market has been geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The North America region accounted for a significant market revenue share in 2022. The growing cases of targeted diseases in North America are boosting regional growth. The development of innovative drug delivery technologies, including oral thin films, has enabled the delivery of drugs in a more targeted and efficient manner. This has resulted in increased adoption of oral thin film products in the region. Patients in North America are increasingly seeking more comfortable and patient-friendly, non-invasive drug delivery options. Oral thin films, a non-invasive drug delivery system, are gaining traction among patients, contributing to the market’s growth. The governments in the region are taking initiatives to create awareness related to the advantages of oral thin films, which are boosting regional growth. Moreover, increased healthcare spending and improved access to healthcare services, with the presence of well-developed healthcare infrastructure is also fueling the growth of the North American region. Key players in the North American oral thin films market are forming strategic collaborations and partnerships to enhance their product offerings and expand their market presence. This is leading to increased adoption of oral thin film products in the region.
Competitive Landscape
The prominent players operating in the global oral thin filmsmarket are:
Strategic Developments
The prominent players operating in the global oral thin films market are CURE Pharmaceutical, ZIM Laboratories Limited, C.L.Pharm Co. Ltd., IntelGenx Corp., and Aquestive Therapeutics, Inc. among others.
The sublingual film segment dominated the global oral thin films market.
North America has the largest market share in terms of revenue. Asia Pacific has the fastest growth rate, which can be considered the key growth region due to the rapid market developments.
The estimated size of the global oral thin films market in 2031 is US$ 5.41 billion.
During the forecast period, the revenue CAGR of the global oral thin films market is estimated to be 8.5%.
*Insights on financial performance are subject to the availability of information in the public domain
Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.
GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.
Snehal Deshmukh
Principle Consultant
Speak to analyst